Candida Infections Prophylaxis in Hematopoietic Stem Cell Transplant Recipients
📧 Sign up to get email alerts when something new happens for Candida Infections Prophylaxis in Hematopoietic Stem Cell Transplant Recipients.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-07-09FDA Approved: MICAFUNGIN — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approves Hikma Pharmaceuticals USA Inc.'s original ANDA for micafungin sodium injectable (micafungin).